Dr. Ramneesh Baweja, MD

NPI: 1548525413
Total Payments
$451.06
2022 Payments
$23.64
Companies
10
Transactions
29
Medicare Patients
868
Medicare Billing
$188,356

Payment Breakdown by Category

Food & Beverage$421.07 (93.4%)
Education$29.99 (6.6%)
Other$0.00 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $421.07 28 93.4%
Education $29.99 1 6.6%

Top Paying Companies

Company Total Records Latest Year
Otsuka America Pharmaceutical, Inc. $140.47 9 $0 (2019)
Allergan, Inc. $116.11 7 $0 (2020)
Janssen Pharmaceuticals, Inc $59.34 4 $0 (2020)
Indivior Inc. $31.47 2 $0 (2018)
Takeda Pharmaceuticals U.S.A., Inc. $25.07 2 $0 (2019)
ABBVIE INC. $23.64 1 $0 (2022)
Eisai Inc. $14.79 1 $0 (2021)
Shire North American Group Inc $14.33 1 $0 (2019)
Teva Pharmaceuticals USA, Inc. $13.74 1 $0 (2019)
Lundbeck LLC $12.10 1 $0 (2019)

Payment History by Year

Year Amount Transactions Top Company
2022 $23.64 1 ABBVIE INC. ($23.64)
2021 $14.79 1 Eisai Inc. ($14.79)
2020 $34.76 2 Janssen Pharmaceuticals, Inc ($21.42)
2019 $248.49 17 Otsuka America Pharmaceutical, Inc. ($86.74)
2018 $129.38 8 Otsuka America Pharmaceutical, Inc. ($53.73)

All Payment Transactions

29 individual payment records from CMS Open Payments — Page 1 of 2

Date Company Product Nature Form Amount Type
05/17/2022 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $23.64 General
Category: NEUROSCIENCE
01/13/2021 Eisai Inc. Dayvigo (Drug) Food and Beverage Cash or cash equivalent $14.79 General
Category: Neurology
02/04/2020 Janssen Pharmaceuticals, Inc SPRAVATO (Drug), INVEGA SUSTENNA, INVEGA TRINZA Food and Beverage In-kind items and services $21.42 General
Category: Neuroscience
01/28/2020 Allergan, Inc. VRAYLAR (Drug) Food and Beverage In-kind items and services $13.34 General
Category: NEUROSCIENCE
11/26/2019 Otsuka America Pharmaceutical, Inc. REXULTI (Drug) Food and Beverage In-kind items and services $21.92 General
Category: PSYCHIATRY
10/21/2019 Otsuka America Pharmaceutical, Inc. REXULTI (Drug) Food and Beverage In-kind items and services $15.78 General
Category: PSYCHIATRY
10/17/2019 Allergan Inc. VRAYLAR (Drug) Food and Beverage In-kind items and services $16.28 General
Category: NEUROSCIENCE
10/15/2019 Janssen Pharmaceuticals, Inc INVEGA TRINZA (Drug), INVEGA SUSTENNA, SPRAVATO Food and Beverage In-kind items and services $15.95 General
Category: Neuroscience
09/04/2019 Allergan Inc. VRAYLAR (Drug) Food and Beverage In-kind items and services $13.32 General
Category: NEUROSCIENCE
08/26/2019 Otsuka America Pharmaceutical, Inc. REXULTI (Drug) Food and Beverage In-kind items and services $15.18 General
Category: PSYCHIATRY
07/18/2019 Janssen Pharmaceuticals, Inc INVEGA SUSTENNA (Drug), INVEGA TRINZA, SPRAVATO Food and Beverage In-kind items and services $10.99 General
Category: Neuroscience
07/01/2019 Otsuka America Pharmaceutical, Inc. REXULTI (Drug) Food and Beverage In-kind items and services $17.75 General
Category: PSYCHIATRY
06/12/2019 Teva Pharmaceuticals USA, Inc. AUSTEDO (Drug) Food and Beverage In-kind items and services $13.74 General
Category: Central Nervous System
05/20/2019 Shire North American Group Inc TRINTELLIX (Drug) Food and Beverage In-kind items and services $14.33 General
Category: NEUROSCIENCE
02/25/2019 Janssen Pharmaceuticals, Inc INVEGA SUSTENNA (Drug), INVEGA TRINZA Food and Beverage In-kind items and services $10.98 General
Category: Neuroscience
02/18/2019 Lundbeck LLC REXULTI (Drug) Food and Beverage Cash or cash equivalent $12.10 General
Category: PSYCHIATRY
02/07/2019 Otsuka America Pharmaceutical, Inc. REXULTI (Drug) Food and Beverage In-kind items and services $16.11 General
Category: PSYCHIATRY
02/07/2019 Takeda Pharmaceuticals U.S.A., Inc. Trintellix (Drug) Food and Beverage In-kind items and services $12.00 General
Category: Central Nervous System (CNS)
02/06/2019 Allergan Inc. VRAYLAR (Drug) Food and Beverage In-kind items and services $17.44 General
Category: NEUROSCIENCE
01/15/2019 Allergan Inc. VRAYLAR (Drug) Food and Beverage In-kind items and services $11.55 General
Category: NEUROSCIENCE
01/10/2019 Takeda Pharmaceuticals U.S.A., Inc. Trintellix (Drug) Food and Beverage In-kind items and services $13.07 General
Category: Central Nervous System (CNS)
12/04/2018 Indivior Inc. SUBLOCADE (Drug) Food and Beverage In-kind items and services $17.83 General
Category: OUD
11/05/2018 Indivior Inc. SUBLOCADE (Drug), SUBOXONE SUBLINGUAL FILM Food and Beverage In-kind items and services $13.64 General
Category: OUD
10/29/2018 Otsuka America Pharmaceutical, Inc. REXULTI (Drug) Food and Beverage In-kind items and services $11.78 General
Category: PSYCHIATRY
09/10/2018 Otsuka America Pharmaceutical, Inc. REXULTI (Drug) Food and Beverage In-kind items and services $11.47 General
Category: PSYCHIATRY

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 3 143 467 $87,068 $27,349
2022 3 191 737 $132,102 $49,434
2021 3 249 873 $157,000 $63,853
2020 5 285 704 $131,805 $47,720
Total Patients
868
Total Services
2,781
Medicare Billing
$188,356
Procedure Codes
14

All Medicare Procedures & Services

14 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 63 260 $55,120 $17,076 31.0%
90833 Psychotherapy with evaluation and management visit, 30 minutes Office 2023 63 190 $26,421 $8,220 31.1%
90792 Psychiatric diagnostic evaluation with medical services Office 2023 17 17 $5,527 $2,052 37.1%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 86 355 $75,260 $29,073 38.6%
90833 Psychotherapy with evaluation and management visit, 30 minutes Office 2022 85 362 $50,340 $17,853 35.5%
90792 Psychiatric diagnostic evaluation with medical services Office 2022 20 20 $6,502 $2,508 38.6%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 112 424 $89,911 $38,618 43.0%
90833 Psychotherapy performed with evaluation and management visit, 30 minutes Office 2021 112 424 $58,961 $21,814 37.0%
90792 Psychiatric diagnostic evaluation with medical services Office 2021 25 25 $8,128 $3,421 42.1%
99214 Established patient office or other outpatient, visit typically 25 minutes Office 2020 110 331 $70,172 $25,061 35.7%
90833 Psychotherapy, 30 minutes Office 2020 105 300 $41,718 $16,009 38.4%
90792 Psychiatric diagnostic evaluation with medical services Office 2020 36 36 $11,704 $3,871 33.1%
99215 Established patient office or other outpatient, visit typically 40 minutes Office 2020 20 20 $5,780 $1,788 30.9%
99213 Established patient office or other outpatient visit, typically 15 minutes Office 2020 14 17 $2,431 $992.35 40.8%

About Dr. Ramneesh Baweja, MD

Dr. Ramneesh Baweja, MD is a Psychiatry healthcare provider based in Texarkana, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/06/2012. The National Provider Identifier (NPI) number assigned to this provider is 1548525413.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ramneesh Baweja, MD has received a total of $451.06 in payments from pharmaceutical and medical device companies, with $23.64 received in 2022. These payments were reported across 29 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($421.07).

As a Medicare-enrolled provider, Baweja has provided services to 868 Medicare beneficiaries, totaling 2,781 services with total Medicare billing of $188,356. Data is available for 4 years (2020–2023), covering 14 distinct procedure/service records.

Practice Information

  • Specialty Psychiatry
  • Other Specialties Psychiatry, Psychiatry
  • Location Texarkana, TX
  • Active Since 07/06/2012
  • Last Updated 02/18/2025
  • Taxonomy Code 2084P0800X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1548525413

Products in Payments

  • VRAYLAR (Drug) $139.75
  • REXULTI (Drug) $137.95
  • SUBLOCADE (Drug) $31.47
  • Trintellix (Drug) $25.07
  • INVEGA SUSTENNA (Drug) $21.97
  • SPRAVATO (Drug) $21.42
  • INVEGA TRINZA (Drug) $15.95
  • Dayvigo (Drug) $14.79
  • ABILIFY MAINTENA (Drug) $14.62
  • TRINTELLIX (Drug) $14.33
  • AUSTEDO (Drug) $13.74

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Psychiatry Doctors in Texarkana